AbbVie (ABBV) Revenue — Quarter Ended Jun 30, 2024
Revenue grew strongly from the previous quarter and also rose compared to the same period last year. The sequential increase was particularly notable.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q2
Revenue grew strongly from the previous quarter and also rose compared to the same period last year. The sequential increase was particularly notable.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$14.5B
Revenue reported for this quarter.
Quarter-over-quarter
+17.5%
Change from the immediately preceding quarter.
Year-over-year
+4.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$55B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $13.9B | -6.0% |
| Dec 31, 2023 | $14.3B | -5.4% |
| Mar 31, 2024 | $12.3B | +0.7% |
| Jun 30, 2024 | $14.5B | +4.3% |
Revenue performance
The company reported higher revenue than both the immediately preceding quarter and the same quarter one year earlier.
Quarterly comparison
Sequentially, revenue increased sharply from the first quarter of the fiscal year. On an annual basis, revenue also grew, but at a more moderate pace.
What to watch
Monitor whether the strong sequential revenue growth can be sustained in future quarters.